| A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo SS Kuduvalli, PS Daisy, A Vaithy, M Purushothaman, ... Frontiers in pharmacology 14, 1096614, 2023 | 5 | 2023 |
| A mutation-agnostic hematopoietic stem cell gene therapy for metachromatic leukodystrophy JS Antony, A Daniel-Moreno, A Lamsfus-Calle, J Raju, M Kaftancioglu, ... The CRISPR Journal 5 (1), 66-79, 2022 | 11 | 2022 |
| Accelerated generation of gene‐engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9 JS Antony, AM Herranz, T Mohammadian Gol, S Mailand, P Monnier, ... Biotechnology Journal 19 (4), 2300505, 2024 | 1 | 2024 |
| Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis A Mishra, JS Antony, P Sundaravadivel, HV Tong, CG Meyer, RD Jalli, ... PLoS One 10 (5), e0125940, 2015 | 23 | 2015 |
| Association of ficolin-2 serum levels and FCN2 genetic variants with Indian visceral leishmaniasis. AM Anshuman Mishra, JS Antony, PS Pandarisamy Sundaravadivel, ... | | 2015 |
| Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing Y Hou, G Ureña-Bailén, T Mohammadian Gol, PG Gratz, HP Gratz, ... Genes 13 (12), 2348, 2022 | 6 | 2022 |
| Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis AKMA Haque, A Dewerth, JS Antony, J Riethmüller, GR Schweizer, ... Scientific reports 8 (1), 16776, 2018 | 71 | 2018 |
| CHEMICALLY MODIFIED mRNA FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH THE CFTR GENE M Kormann, A Dewerth, A Haque, JS Antony US Patent App. 16/673,853, 2020 | 2 | 2020 |
| Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies A Daniel-Moreno, A Lamsfus-Calle, A Wilber, CB Chambers, I Johnston, ... Blood Cells, Molecules, and Diseases 84, 102456, 2020 | 4 | 2020 |
| Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin A Lamsfus-Calle, A Daniel-Moreno, JS Antony, T Epting, L Heumos, ... Scientific reports 10 (1), 10133, 2020 | 52 | 2020 |
| COMPLEMENT LECTIN PATHWAY PROTEINS AND URINARY SCHISTOSOMIASIS JS Antony | | |
| Correlation of Interleukin-6 levels and lectins during Schistosoma haematobium infection JS Antony, O Ojurongbe, CG Meyer, K Thangaraj, A Mishra, PG Kremsner, ... Cytokine 76 (2), 152-155, 2015 | 12 | 2015 |
| Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo SS Kuduvalli, PS Daisy, A Vaithy, M Purushothaman, AR Muralidharan, ... Frontiers in Pharmacology 14, 1322332, 2024 | | 2024 |
| CRISPR medicine for blood disorders: progress and challenges in delivery T Mohammadian Gol, G Ureña-Bailén, Y Hou, R Sinn, JS Antony, ... Frontiers in Genome Editing 4, 1037290, 2023 | 4 | 2023 |
| CRISPR Medicine: Advance, Progress and Challenges G Ureña-Bailén, JS Antony, Y Hou, J Raju, A Lamsfus-Calle, ... CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and …, 2022 | | 2022 |
| CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells T Mohammadian Gol, M Kim, R Sinn, G Ureña-Bailén, S Stegmeyer, ... International Journal of Molecular Sciences 24 (22), 16065, 2023 | 1 | 2023 |
| CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases JS Antony, AKMA Haque, A Lamsfus‐Calle, A Daniel‐Moreno, M Mezger, ... Advances in Cell and Gene Therapy 1 (1), e10, 2018 | 20 | 2018 |
| CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies G Ureña-Bailén, A Lamsfus-Calle, A Daniel-Moreno, J Raju, P Schlegel, ... Briefings in functional genomics 19 (3), 191-200, 2020 | 23 | 2020 |
| CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation A Daniel-Moreno, A Lamsfus-Calle, J Raju, JS Antony, R Handgretinger, ... Bone Marrow Transplantation 54 (12), 1940-1950, 2019 | 38 | 2019 |
| Functional Gene Correction of Cystic Fibrosis Using In Vitro Transcribed Cas9 mRNA JS Antony MOLECULAR THERAPY 25 (5), 86-86, 2017 | | 2017 |
